Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control

Publisher: Cambridge University Press

E-ISSN: 2165-6509|22|4|333-341

ISSN: 1092-8529

Source: CNS Spectrums, Vol.22, Iss.4, 2016-11, pp. : 333-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content